GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Institutional Ownership

AngioDynamics (FRA:UG2) Institutional Ownership : 31.99% (As of May. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AngioDynamics's institutional ownership is 31.99%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AngioDynamics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AngioDynamics's Float Percentage Of Total Shares Outstanding is 78.20%.


AngioDynamics Institutional Ownership Historical Data

The historical data trend for AngioDynamics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Institutional Ownership Chart

AngioDynamics Historical Data

The historical data trend for AngioDynamics can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 57.07 56.11 36.75 33.85 32.50 33.21 32.97 32.27 32.28 31.99

AngioDynamics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


AngioDynamics (FRA:UG2) Business Description

Traded in Other Exchanges
Address
14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

AngioDynamics (FRA:UG2) Headlines

No Headlines